Case report: verapamil-induced subacute cutaneous lupus erythematosus.

Boaz Kurtis, Matthew J. Larson, Mai P. Hoang, Jack B. Cohen

Research output: Contribution to journalArticle

10 Scopus citations


Calcium-channel blockers (CCB), including verapamil, nifedipine, and diltiazem, are one of the most widely prescribed class of drugs in the treatment of cardiovascular disease. In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.

Original languageEnglish (US)
Pages (from-to)506-508
Number of pages3
JournalJournal of drugs in dermatology : JDD
Issue number4
StatePublished - Jan 1 2005


ASJC Scopus subject areas

  • Dermatology

Cite this